Polygenic risk scores may miss the mark when predicting aggressive prostate cancers

According to a research letter published in JAMA Internal Medicine, prostate cancer screening frequently results in biopsies that find clinically insignificant cancer or no cancer at all.

Leave A Comment

Your email address will not be published. Required fields are marked *